Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition

Miao, Liyun; Zhu, Suhua; Wang, Yongsheng; Li, Yan; Ding, Jingjing; Dai, Jinghong; Cai, Hourong; Zhang, Deping; Song, Yong
September 2013
Medical Oncology;Sep2013, Vol. 30 Issue 3, p1
Academic Journal
No abstract available.


Related Articles

  • Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer. Tangfeng Lv; Dongmei Yuan; Xiaohui Miao; Yanling Lv; Ping Zhan; Xiaokun Shen; Yong Song // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: Lysine specific demethylase 1 (LSD1) has been identified and biochemically characterized in epigenetics, but the pathological roles of its dysfunction in lung cancer remain to be elucidated. The aim of this study was to evaluate the prognostic significance of LSD1 expression in...

  • Frontal GABA Levels Change during Working Memory. Michels, Lars; Martin, Ernst; Klaver, Peter; Edden, Richard; Zelaya, Fernando; Lythgoe, David J.; Lüchinger, Rafael; Brandeis, Daniel; O'Gorman, Ruth L. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Functional neuroimaging metrics are thought to reflect changes in neurotransmitter flux, but changes in neurotransmitter levels have not been demonstrated in humans during a cognitive task, and the relationship between neurotransmitter dynamics and hemodynamic activity during cognition has not...

  • Discoidin Domain Receptor 1 Contributes to Tumorigenesis through Modulation of TGFBI Expression. Rudra-Ganguly, Nandini; Lowe, Christine; Mattie, Michael; Chang, Mi Sook; Satpayev, Daulet; Verlinsky, Alla; An, Zili; Hu, Liping; Yang, Peng; Challita-Eid, Pia; Stover, David R.; Pereira, Daniel S. // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Discoidin domain receptor 1 (DDR1) is a member of the receptor tyrosine kinase family. The receptor is activated upon binding to its ligand, collagen, and plays a crucial role in many fundamental processes such as cell differentiation, adhesion, migration and invasion. Although DDR1 is expressed...

  • Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition. Lin, Steven H.; Jing Wang; Saintigny, Pierre; Chia-Chin Wu; Giri, Uma; Jing Zhang; Toshi Menju; Diao, Lixia; Byers, Lauren; Weinstein, John N.; Coombes, Kevin R.; Girard, Luc; Komaki, Ritsuko; Wistuba, Ignacio I.; Date, Hiroshi; Minna, John D.; Heymach, John V. // BMC Genomics;2014, Vol. 15 Issue 1, p591 

    Background: DNA methylation is associated with aberrant gene expression in cancer, and has been shown to correlate with therapeutic response and disease prognosis in some types of cancer. We sought to investigate the biological significance of DNA methylation in lung cancer. Results: We...

  • Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. Ford, C. E.; Lau, S. K.; Zhu, C. Q.; Andersson, T.; Tsao, M. S.; Vogel, W. F. // British Journal of Cancer;3/12/2007, Vol. 96 Issue 5, p808 

    The discoidin domain receptors, (DDR)1 and DDR2, have been linked to numerous human cancers. We sought to determine expression levels of DDRs in human lung cancer, investigate prognostic determinates, and determine the prevalence of recently reported mutations in these receptor tyrosine kinases....

  • YXQ-EQ Induces Apoptosis and Inhibits Signaling Pathways Important for Metastasis in Non-Small Cell Lung Carcinoma Cells. Xin Yan; Hua Shen; Hongjian Jiang; Dan Hu; Jun Wang; Xinqi Wu // Cellular Physiology & Biochemistry (Karger AG);Oct2018, Vol. 49 Issue 3, p911 

    Background/Aims: Lung cancer is one of the most prevalent malignancies in the world. The 5-year survival rate for non-small cell lung cancer (NSCLC) patients is only approximately 15%, with metastasis as the primary cause of death. This study was aimed to investigate cytotoxic effect of external...

  • Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. Shen, Liqin; Chen, Lei; Wang, Yongsheng; Jiang, Xiaochun; Xia, Hongping; Zhuang, Zhixiang // Journal of Neuro-Oncology;Jan2015, Vol. 121 Issue 1, p101 

    Brain metastasis often has a poor prognosis in patients with advanced non-small cell lung cancer (NSCLC). Therefore, it is urgent to identify factors associated with lung cancer brain metastasis. Metastasis associated lung adenocarcinoma transcript 1 (MALAT1) also known as noncoding...

  • Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients. Liyun Miao; Yongsheng Wang; Suhua Zhu; Minke Shi; Yan Li; Jingjing Ding; Jun Yang; Qing Ye; Hourong Cai; Deping Zhang; Hongbing Iiu; Yong Song // BMC Cancer;2014, Vol. 14 Issue 1, p713 

    Background Although many of the recently approved genomically targeted therapies have improved outcomes for patients in non-small-cell lung cancer (NSCLC) with lung adenocarcinoma, little is known about the genomic alterations that drive lung squamous cell cancer (SCC) and development of...

  • Expression of Beclin-1 in the Microenvironment of Invasive Ductal Carcinoma of the Breast: Correlation with Prognosis and the Cancer-Stromal Interaction. Morikawa, Akemi; Takeuchi, Tamotsu; Kito, Yusuke; Saigo, Chiemi; Sakuratani, Takuji; Futamura, Manabu; Yoshida, Kazuhiro // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    We examined the pathobiological properties of beclin-1, which is a key regulator of autophagosome formation in invasive ductal carcinoma of the breast, with a particular focus on the cancer microenvironment. Immunohistochemistry demonstrated that cancer cells and stromal mesenchymal cells...

  • EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Sánchez-Tilló, Ester; Liu, Yongqing; Barrios, Oriol; Siles, Laura; Fanlo, Lucia; Cuatrecasas, Miriam; Darling, Douglas; Dean, Douglas; Castells, Antoni; Postigo, Antonio // Cellular & Molecular Life Sciences;Oct2012, Vol. 69 Issue 20, p3429 

    Cancer is a complex multistep process involving genetic and epigenetic changes that eventually result in the activation of oncogenic pathways and/or inactivation of tumor suppressor signals. During cancer progression, cancer cells acquire a number of hallmarks that promote tumor growth and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics